These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 2481664

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Lymphokine-activated killer (LAK) cells. V. 8-Mercaptoguanosine as an IL-2-sparing agent in LAK generation.
    Thompson RA, Ballas ZK.
    J Immunol; 1990 Nov 15; 145(10):3524-31. PubMed ID: 1700014
    [Abstract] [Full Text] [Related]

  • 23. Effective in vivo induction of lymphokine-activated killer (LAK) cells by pretreatment with a streptococcal preparation, OK-432.
    Shimoda K, Saito T, Kobayashi M, Nomoto K.
    Biotherapy; 1992 Nov 15; 5(1):63-9. PubMed ID: 1389903
    [Abstract] [Full Text] [Related]

  • 24. Phytochemicals potentiate interleukin-2 generated lymphokine-activated killer cell cytotoxicity against murine renal cell carcinoma.
    Wang Y, Qian XJ, Hadley HR, Lau BH.
    Mol Biother; 1992 Sep 15; 4(3):143-6. PubMed ID: 1445669
    [Abstract] [Full Text] [Related]

  • 25. Effect of granulocyte-macrophage colony-stimulating factor on lymphokine-activated killer cell induction.
    Stewart-Akers AM, Cairns JS, Tweardy DJ, McCarthy SA.
    Blood; 1993 May 15; 81(10):2671-8. PubMed ID: 8490177
    [Abstract] [Full Text] [Related]

  • 26. Characteristics of interleukin-6-enhanced lymphokine-activated killer cell function.
    Iho S, Shau HY, Golub SH.
    Cell Immunol; 1991 Jun 15; 135(1):66-77. PubMed ID: 2018984
    [Abstract] [Full Text] [Related]

  • 27. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL, Herberman RB, Olszowy MW, Cramer DV, Salup RR, Reynolds CW, Hiserodt JC.
    Cancer Res; 1988 Feb 15; 48(4):884-90. PubMed ID: 3257412
    [Abstract] [Full Text] [Related]

  • 28. Augmented production of colony-stimulating factor in C3H/HeN mice immunized with Nocardia rubra cell wall skeleton.
    Hayashi S, Masuno T, Hosoe S, Kawase I, Sakatani M, Ogura T, Kishimoto S, Yamamura Y.
    Infect Immun; 1986 Apr 15; 52(1):128-33. PubMed ID: 3082754
    [Abstract] [Full Text] [Related]

  • 29. Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells.
    Gemlo BT, Palladino MA, Jaffe HS, Espevik TP, Rayner AA.
    Cancer Res; 1988 Oct 15; 48(20):5864-7. PubMed ID: 3139285
    [Abstract] [Full Text] [Related]

  • 30. Effects of tumour necrosis factor-alpha (TNF-alpha), IL-1 beta and monocytes on lymphokine-activated killer (LAK) induction from natural killer (NK) cells and T lymphocytes.
    Yoneda K, Osaki T, Yamamoto T, Ueta E.
    Clin Exp Immunol; 1993 Aug 15; 93(2):229-36. PubMed ID: 8348749
    [Abstract] [Full Text] [Related]

  • 31. Human blood monocyte activation by Nocardia rubra cell wall skeleton for productions of interleukin 1 and tumor necrosis factor-alpha.
    Inamura N, Sone S, Ogawa T, Nishio M, Ogura T.
    Biotherapy; 1992 Aug 15; 4(2):155-63. PubMed ID: 1622735
    [Abstract] [Full Text] [Related]

  • 32. Induction of interleukin 3 but not interleukin 2 or interferon production in the syngeneic mixed lymphocyte reaction.
    Suzuki R, Suzuki S, Igarashi M, Kumagai K.
    J Immunol; 1986 Sep 01; 137(5):1564-72. PubMed ID: 2427574
    [Abstract] [Full Text] [Related]

  • 33. Enhancement of murine lymphokine-activated killer cell activity by retinoic acid.
    Lin TH, Chu TM.
    Cancer Res; 1990 May 15; 50(10):3013-8. PubMed ID: 1970751
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Growth of MCF-7 human breast carcinoma in severe combined immunodeficient mice: growth suppression by recombinant interleukin-2 treatment and role of lymphokine-activated killer cells.
    Zhai YF, Esselman WJ, Oakley CS, Chang CC, Welsch CW.
    Cancer Immunol Immunother; 1992 May 15; 35(4):237-45. PubMed ID: 1511458
    [Abstract] [Full Text] [Related]

  • 36. Possible involvement of a tumor necrosis factor (TNF)-like mediator as an endogenous pyrogen in fever induction by Nocardia rubra cell wall skeleton (N-CWS).
    Ohara K, Hirano Y, Ishida H, Mori J, Tensho A.
    Chem Pharm Bull (Tokyo); 1989 Oct 15; 37(10):2795-8. PubMed ID: 2611940
    [Abstract] [Full Text] [Related]

  • 37. rIL-4 differentially regulates rIL-2-induced murine NK and LAK killing in CD8+ and CD8- precursor cell subsets.
    Merrow MW, Huber BT.
    Int Immunol; 1991 Jun 15; 3(6):551-61. PubMed ID: 1909562
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Acidic polysaccharide from Panax ginseng, ginsan, induces Th1 cell and macrophage cytokines and generates LAK cells in synergy with rIL-2.
    Kim KH, Lee YS, Jung IS, Park SY, Chung HY, Lee IR, Yun YS.
    Planta Med; 1998 Mar 15; 64(2):110-5. PubMed ID: 9525101
    [Abstract] [Full Text] [Related]

  • 40. Distinct antitumor mechanisms of recombinant interleukin-2 on recombinant interleukin-2-activated killer-sensitive and -resistant murine tumors.
    Maekawa R, Kitagawa T, Koizumi K, Sato K, Homma M.
    J Biol Response Mod; 1989 Dec 15; 8(6):676-90. PubMed ID: 2600605
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.